Pharmaceutial Pricing and Reimbursement in ChinaDecision ResourcesJune 29, 2009 31 Pages - SKU: DECR2303161 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Herbal/Traditional Products in Ukraine
5/10/2012 | published by: Euromonitor International
In 2011, retail value sales in herbal/traditional products increased by 10% in current terms to UAH742 million. Even though sales were partly boosted by rising prices of consumer health products, including herbal/traditional products, Ukrainians still
|
more...
|
$900.00
|
|
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
5/15/2012 | published by: GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
Summary
GBI Research, the leading
|
more...
|
$3,500.00
|
|
Herbal/Traditional Products in Dominican Republic
5/9/2012 | published by: Euromonitor International
Dominican Republic has a strong culture of traditional and remedies, usually transmitted from one generation another. These remedies are usually made from plants available in the wild, then processed to treat different illnesses. Those remedies
|
more...
|
$900.00
|
|
Herbal/Traditional Products in Latvia
5/8/2012 | published by: Euromonitor International
Herbal/traditional products had faster growth than standard products in Latvia in 2011. Herbal/traditional products were present in almost all of consumer health and were more active in terms of new launches and developments compared to
|
more...
|
$900.00
|
|
Herbal/Traditional Products in Guatemala
5/10/2012 | published by: Euromonitor International
In 2011, current value sales of herbal/traditional products grew by 11% to GTQ33 million. The category’s performance is mainly boosted by herbal cough, cold and allergy (hay fever) remedies together with herbal/traditional vitamins and dietary
|
more...
|
$900.00
|
|
Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2012 Q2 Release]
4/16/2012 | published by: Supplier Relations US, LLC
This latest Biological Product (except Diagnostic) Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data,
|
more...
|
$599.00
|
|
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
4/30/2012 | published by: GBI Research
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules Summary GBI Research, the leading business intelligence provider, has released its latest research
|
more...
|
$3,500.00
|
|
Pharmaceutical Preparation Manufacturing Industry in the U.S. and its International Trade [2012 Q2 Release]
4/16/2012 | published by: Supplier Relations US, LLC
This latest Pharmaceutical Preparation Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data, upstream and
|
more...
|
$799.00
|
|
Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
4/30/2012 | published by: GBI Research
Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation Summary GBI Research, the leading business intelligence provider, has released its latest research “Orphan Disease
|
more...
|
$3,500.00
|
Related Markets
- Healthcare
- Alternative & Complementary Medicine
- Insurance & Managed Care
- Insurance & Managed Care Company Reports
- Pharmaceuticals
- Manufacturing, Packaging & Detailing
Manufacturing, Packaging & Detailing Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Perspective: TAKE Solutions Gives Leading Pharma an Edge in Drug Serialization
- The World Market for Over The Counter (OTC) Drugs
- Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
- Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion
